Zoumana Traoré¹*, Modibo Sangaré², Kankou Traoré³, Seybou Hassane Diallo³, Adama Seydou Sissoko⁴, Thomas Coulibaly⁴, Salimata Diallo³, Guida Landouré⁴, Massaman Camara⁵, Youssouf Sogoba³, Cheick Oumar Guinto⁴ and Youssoufa Maiga³

¹Medical Department, Mali Hospital, Bamako, Mali
²Faculty of Medicine and Odonto-Stomatology, University of Bamako, Mali
³Neurology Department, Gabriel Touré Hospital and University Center, Bamako, Mali
⁴Neurology Department, Point G Hospital and University Center, Bamako, Mali
⁵Department of Medicine, Kati Hospital and University Center, Koulikoro, Mali

*Corresponding Author: Zoumana Traoré, Medical Department, Mali Hospital, Bamako, Mali.

Received: April 10, 2021; Published: June 04, 2021

Abstract

Subarachnoid hemorrhage (SAH) is a form of stroke less represented in terms of incidence, however, the first in terms of morbidity and mortality. Our goal is to study the epidemiological, clinical, therapeutic and prognostic aspects of subarachnoid hemorrhage (SAH).

Methodology: This study was conducted in the Department of Neurology at Gabriel Touré University Hospital in Bamako. This is a retrospective study of inpatient records for SAH in Neurology between January 2011 and December 2016. All cases of spontaneous SAH, confirmed by a brain scan, were included. Cases of traumatic SAH, cases of systemic hemorrhagic stroke with ventricular break-in were not included. Fisher scale was used to categorize patients.

Results: We collected 41 patients including 20 men and 21 women. Patients aged 40-59 years were the most represented (n = 24). Nineteen patients (46.34%) had no known risk factors. The main cause of admission was 51.22% isolated headache (n = 21). On examination, the meningeal syndrome was present and complete in 70.73% (n = 29). Six patients did not receive Nimodipine and four of these patients experienced vasospasm during their hospital stay. There was a mortality of 21.95% (n = 9).

Conclusion: Our study confirms the data of African literature. The frequency of SAH is underestimated due to a lack of appropriate diagnostic means.

Keywords: Bamako; Department of Neurology at Gabriel Touré; Subarachnoid Haemorrhage

References

1. Friedman JA., et al. “Pulmonary complications of aneurysmal subarachnoid hemorrhage”. Neurosurgerie5 (2003): 1025-1032.
2. Grasso G., et al. “Management of aneurysmal subarachnoid hemorrhage: State of the art and future perspectives”. Surgical Neurology International 8 (2017): 10-11.
3. Huttunen J., et al. “Epilepsy-associated long term mortality after aneuvrysmal subarachnoid hemorrhage”. Neurology3 (2017): 268-263.
4. Ahanogbe KMH., et al. “Problem of meningemorrhages in developing countries: Case of Togo”. Neurosurgery 6 (2016): 316-312.
5. Korja M., et al. “Risk Factors and heir Combined Effects on the Incidence Rate of Subarachnoid Hemorrhage – A Population-Based Cohort Study”. PLoS One9 (2013): 7-11.
6. El Khamlichi A., et al. “Pattern of Cerebral Aneurysms in Morocco: Review of the Concept of Their Rarity in Developing Countries: Report of 200 Cases”. Neurosurgery5 (2001): 1224-1229.
7. Ogungbo B., et al. “The epidemiology, diagnosis and treatment of subarachnoid haemorrhage in Nigeria: what do we know and what do we need to know?” British Journal of Neurosurgery4 (2004): 362-366.
8. Song JP., et al. “Epidemiological Features of Nontraumatic Spontaneous Subarachnoid Hemorrhage in China: A Nationwide Hospital‑based Multicenter Study”. Chinese Medical Journal (Engl). 130.7 (2017): 781-776.
9. Lieshout JHV., et al. “Subarachnoid Hemorrhage in Germany Between 2010 and 2013: Estimated Incidence Rates Based on a Nationwide Hospital Discharge Registry”. World Neurosurgery 104 (2017): 521-516.
10. Diallo SH., et al. “Epidemiological, clinical and therapeutic profile of patients hospitalized in the Neurology department of the Gabriel Touré University Hospital in 2016”. RISM2 (2019): 124-129.
11. Lindbohm JV., et al. “Sex, Smoking, and Risk for Subarachnoid Hemorrhage”. Stroke8 (2016): 1975-1981.
12. Tarnoki AD., et al. “Relationship between weather conditions and admissions for ischemic stroke and subarachnoid hemorrhage”. Croatian Medical Journal 1 (2017): 56-62.
13. Diallo T. “Seasonal Variations and Strokes: Study of 219 cases at the Point G University Hospital [Doctoral Thesis in General Medicine]. Bamako: University of Bamako Faculty of Medicine (2008).
14. Seiller N., et al. “Meningeal Hemorrhages”. Encycl Méd Chir (Scientific and Medical Editions Elsevier SAS, Paris, all rights reserved), Neurology (2002): 17.
15. Lee S and Guth M. “Associations between Temperature and Hospital Admissions for Subarachnoid Hemorrhage in Korea”. International Journal of Environmental Research and Public Health 4 (2017): 11-11.
16. Norrgard O., et al. “Intracranial aneurysms and heredity”. Neurosurgery 20 (1987): 2369.
17. Lawton MT and Vates GE. “Subarachnoid Hemorrhage”. The New England Journal of Medicine 377 (2017): 257-266.
18. Long B., et al. “Subarachnoid Hemorrhage: Updates In diagnosis and Management”. Emergency Medicine Clinics of North America 4 (2017): 803-824.
19. Dorhout Mees SM., et al. “Calcium antagonists for aneurysmal subarachnoid haemorrhage”. Cochrane Database System Review 3 (2018): 50-51.
20. Chatterjee S. “ECG changes in subarachnoid haemorrhage: a synopsis”. Netherlands Heart Journal 1 (2010): 31-34.
21. Lee VH., et al. “Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage”. Neurocritical Care3 (2006): 243-249.

Citation

Citation: Zoumana Traoré., et al. “Subarachnoid Hemorrragia in the Neurology Department at the Gabriel Toure Hospital-University Centre: A Five-year Retrospective Study”. Acta Scientific Neurology 4.7 (2021): 03-07.

Copyright

Copyright: © 2021 Zoumana Traoré., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.